News and Trends 2 Sep 2024
Are we in an AI bubble? Biotech AI startups’ value plummet and leads to restructuration
Delve into the downturn AI is experiencing in biotech: Is the bubble bursting or is the market correcting the high expectations?
BenevolentAI
- Latest Posts
News and Trends 8 Mar 2023
How to promote diversity in STEM
Leaders from OMass Therapeutics, SiSaf and Brainomix explain how to promote diversity in science, technology, engineering and math (STEM). OMass Therapeutics is a female-led business with diversity at its core. It was founded by the pioneering scientist and Oxford Professor Dame Carol Robinson and is led by the experienced biotech and pharma executive Ros Deegan. […]
News and Trends 7 Oct 2021
Exscientia IPO Attracts Tech Investor Bets to AI Drug Discovery
Exscientia’s lucrative entry onto the Nasdaq last week demonstrated investors are still excited by efforts to use artificial intelligence to fuel drug discovery, with global tech investors often taking the lead. The Oxford, UK-based company Exscientia has one of the most mature artificial intelligence (AI)-focused drug discovery pipelines, alongside companies like BenevolentAI in the UK, […]
News and Trends 19 Apr 2018
Major $115M Fundraising Fuels AI Drug Development
BenevolentAI has raised a massive second round of fundraising to expand the drug developing capabilities of its artificial intelligence technology. The technology could significantly increase the speed and efficiency of the drug discovery process. BenevelontAI, based in London, has raised an impressive $115M (€93M) to advance its use of AI in drug development. The funding, raised from […]
News and Trends 28 Mar 2018
AI Is Being Put to Work to Treat Parkinson’s Disease in the UK
The artificial intelligence company BenevolentAI is collaborating with two UK charities to use AI to identify ideal drug candidates for treating Parkinson’s disease. BenevolentAI, Europe’s largest private AI company, is collaborating with Parkinson’s UK and The Cure Parkinson’s Trust (CPT), two UK charities, to repurpose at least three existing drugs and identify two novel drug targets […]
In Depth 5 Mar 2018
The Robots are Coming: Is AI the Future of Biotech?
AI, or artificial intelligence, has taken root in biotech. In this article, we explore its newfound niches in the industry. Artificial intelligence (AI) and machine learning (ML) have become ubiquitous in tech startups, fueled largely by the increasing availability and amount of data and cheaper, more powerful computers. Now, if you are a new tech startup, […]
ADVERTISEMENT
ADVERTISEMENT
News and Trends 27 Sep 2017
German Researchers’ Algorithm Can Predict New Targets for Existing Drugs
An algorithm based on the brain’s self-organizing capacity has been developed in Germany that could combat the rising costs of drug development. A team at TU Dresden has pioneered an algorithm that exploits the self-organization of the brain to predict new drug targets, without the need for extra biological or molecular information. The study, published in Briefings […]
In Depth 21 Sep 2017
How Will Artificial Intelligence Impact Alzheimer’s Research?
Last week, worldwide leaders gathered at the Artificial Intelligence in Bioscience Symposium in London to examine the growing role AI plays in healthcare, highlighting neuroscience and particularly Alzheimer’s as one of the most promising applications of this new technology. Within the last few years, the field of bioscience witnessed an exponential expansion, especially with the development […]
Interview 20 Mar 2017
Machines are Helping Healthcare: An Interview with their Biotech Leader
BenevolentAI is leading the charge in artificial intelligence. We talked to Jackie Hunter, who is the CEO of the company’s bioscience arm, BenevolentBio. Jackie Hunter has had quite an impressive career! After defending her PhD in psychology, she transitioned to GSK, where she clocked nearly 20 years in various leadership positions — Director while the […]
News and Trends 9 Nov 2016
British Artificial Intelligence will soon run Clinical Trials
Artificial Intelligence can make clinical trials cheaper and faster, and this British start-up is about to start testing its technology to optimize drug development. BenevolentAI is a London start-up that specializes in artificial intelligence (AI); its BenevolentBio division, formerly Stratified Medical, applies AI to human health and biotech. Its baby is a technology that could speed […]
ADVERTISEMENT